Results per Page:
Magic mushrooms, real results: Psilocybin’s role in healthcare worker healing
From the Gooley Group, Clinical Research Division
Could fecal microbiota transplantation help patients heal after stem cell transplantation?
Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer
Navigating a brand-new cancer diagnosis
Fred Hutch nurse navigation program expands, reducing waiting time for new appointments and treatment
What’s new in breast cancer research? SABCS24 looks at ctDNA, AI and ‘right-sizing’ treatment
Large research symposium highlights liquid biopsies, new drug combos, shifts in surgical practice and, yes, patient voices
Infectious disease experts propose trials network dedicated to immunocompromised patients
ImmunOptimize workshop convened stakeholders across disciplines to brainstorm infectious disease clinical trials network designed to serve people with weakened immune systems
A promising antibody-drug conjugate for treating brain metastases in breast cancer patients
From the Hurvitz Lab, Clinical Research Division
Volunteer patient advocate can’t help helping others
For this podcaster, breast cancer patient and self-described “clinical trials fanatic,” advocacy starts with community building
The exclusion of immunocompromised patients in clinical trials and how we can do better
From Drs. Michael Boeckh, Joshua Hill, Steven Pergam and Larry Corey, Hematologic Malignancies and Cancer Immunology Programs of the Cancer Consortium
20 years since Fred Hutch president helped make EGFR discovery, woman with stage 4 lung cancer is thriving
Dr. Tom Lynch described how targeted therapies could dramatically improve patient outcomes
Dr. Mazyar Shadman, new medical director of the Bezos Family Immunotherapy Clinic, says immunotherapy services are expanding to meet demand
Increasing timely access to immunotherapy is a main goal
When it comes to cancer trials, what’s the (end)point?
New endpoint in multiple myeloma could mean faster drug approvals. Are more endpoint tweaks on the way?
How a Black woman is coping with an ‘old white man’s disease’
Bladder cancer patient manages the stress of a disease where recurrence is common
Una dosis de bortezomib por semana es suficiente para tratar el mieloma múltiple
Del Dr. Rahul Banerjee, División de Investigación Clínica
All eyes on IL-6 when it comes to CMV reactivation after bone marrow transplantation
From the Hill Lab in Translational Sciences and Therapuetics Division
Novel chemoimmunotherapy approach shows promise for B-cell acute lymphoblastic leukemia in phase 1 study at Fred Hutch
DA-EPOCH plus inotuzumab ozogamicin was “safe and highly active” in adults with relapsed or refractory disease
Clinical trials excluding fewer cancer patients with brain ‘mets’
In other news, 1 in 5 people with cancer participate in research studies